Cargando…
Phosphorylated eIF2α predicts disease-free survival in triple-negative breast cancer patients
Phosphorylated eukaryotic translation initiation factor 2α (p-eIF2α), which functions as a marker of endoplasmic reticulum stress, has been reported to be associated with patient prognosis in various cancers. However, little is known about the prognostic value of p-eIF2α in breast cancer, particular...
Autores principales: | Guo, Liang, Chi, Yayun, Xue, Jingyan, Ma, Linxiaoxi, Shao, Zhiming, Wu, Jiong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5353635/ https://www.ncbi.nlm.nih.gov/pubmed/28294178 http://dx.doi.org/10.1038/srep44674 |
Ejemplares similares
-
Novel mechanisms of eIF2B action and regulation by eIF2α phosphorylation
por: Bogorad, Andrew M., et al.
Publicado: (2017) -
Roles of eIF3m in the tumorigenesis of triple negative breast cancer
por: Han, Wei, et al.
Publicado: (2020) -
LINC00309 is associated with short disease-free survival in breast cancer
por: Huang, Sheng, et al.
Publicado: (2019) -
Polycystin-1 inhibits eIF2α phosphorylation and cell apoptosis through a PKR-eIF2α pathway
por: Tang, Yan, et al.
Publicado: (2017) -
Expression of phosphorylated eIF4E-binding protein 1, but not of eIF4E itself, predicts survival in male breast cancer
por: Millican-Slater, Rebecca A, et al.
Publicado: (2016)